Plenary Session 4205

MDS Keynote and Clinical Breakthroughs

Wednesday, October 7, 2026
8:00 - 9:30 | Grand Ballroom, Level 1

(Non-accredited) The MDS Keynote Lecture is an innovative session that welcomes distinguished lecturers to present novel and innovative concepts designed to intrigue and captivate the MDS audience.

Chairs:

Victor Fung, Australia
Maria Stamelou, Greece

Presenters:

Keynote: Immuno-Gerotherapeutics Targeting Senescent Cells for Age-Associated Diseases
Tohru Minamino, Japan

Breakthrough: Subthalamic vs Pallidal Temporal Interference Stimulation for Parkinson Disease: A Randomized Clinical Trial
Adam Williamson, China

Breakthrough: A Phase 2a, Multi Centre, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Effect of 12 Weeks Treatment with Oral PXS-4728A on Microglia Activation, as Measured by PET, in Participants with iRBD
Simon Lewis, Australia

Breakthrough: Results from ARISE: A phase 3 trial of solengepras in Parkinson’s patients with motor fluctuations
Robert Hauser, USA

CSPC Liaison(s):

David Burn, Ireland
Ron Postuma, Canada

Learning Objectives

At the conclusion of this session, participants should be better able to:

1. Understand the role of cellular senescence in neurodegenerative diseases and evaluate emerging immuno-gerotherapeutic strategies targeting senescent cells for therapeutic intervention.

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)
Industry
Researcher / Basic Science

Education Level

Advanced / Expert
Beginner / Foundational
Intermediate / Experienced